FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and concerns pyelonephritis prevention in experiment. During 10 days preparation "Ultrasorb" is introduced to experimental animals with food in terms of 3 g/day. Then pyelonephritis is modelled by rectal infection with uropathogenic strain of lactose-negative E.Coli at the background of cold stress.
EFFECT: absence or reliable reduction of kidney tissue inflammation in animals which obtained "Ultrasorb".
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ACUTE PYELONEPHRITIS SIMULATION WITH UNDERLYING COLD STRESS | 2008 |
|
RU2368016C1 |
METHOD TO PREVENT INFECTIOUS COMPLICATIONS IN ANIMALS UNDER EXPOSURE TO STRESS IN EXPERIMENT | 2009 |
|
RU2410101C1 |
METHOD FOR SIMULATING ACUTE PYELONEPHRITIS WITH UNDERLYING CRYOGENIC EFFECT | 2008 |
|
RU2387019C2 |
METHOD OF ACUTE PYELONEPHRITIS MODELLING | 2007 |
|
RU2349965C1 |
METHOD FOR SIMULATING GESTATIONAL PYELONEPHRITIS | 2013 |
|
RU2532402C1 |
METHOD FOR SIMULATING PYELONEPHRITIS OCCURRING AFTER ENDOUROLOGICAL INTERVENTIONS | 2023 |
|
RU2816780C1 |
WAY OF INTESTINE DYSBACTERIOSIS PREVENTION DURING EXPERIMENT | 2008 |
|
RU2363477C1 |
METHOD FOR MODELING GESTATION PYELONEPHRITIS AT THE BACKGROUND OF INFECTIOUS- INFLAMMATORY PROCESS OF URINARY TRACT | 2000 |
|
RU2202834C2 |
METHOD FOR MODELING INTRAUTERINE INFECTIOUS PROCESS ON THE BACKGROUND OF URINARY TRACT INFECTION | 1999 |
|
RU2197750C2 |
ANTIBACTERIAL COMPOSITION BASED ON STRAINS OF BACTERIOPHAGES FOR PREVENTING OR TREATING SALMONELLOSIS AND / OR ESCHERICHIOSIS OF FARM ANIMALS OR BIRDS OR HUMANS | 2019 |
|
RU2705302C1 |
Authors
Dates
2009-05-10—Published
2007-12-12—Filed